Top broker sees 15% upside in the Webjet (ASX:WEB) share price

Is it time to buy Webjet shares?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Webjet Limited (ASX: WEB) share price is out of form and trading lower on Tuesday.

In afternoon trade, the online travel agent's shares are down 2.5% to $6.09.

travel shares and IPO represented by man holding passport and wads of cash

Image source: Getty Images

Is the weakness in the Webjet share price a buying opportunity?

One leading broker that is likely to see today's weakness in the Webjet share price as a buying opportunity is Goldman Sachs.

This morning the broker released a note looking at the travel sector and spoke very positively about the company.

According to the release, Goldman has retained its buy rating and lifted its price target on the company's shares to $7.00.

Based on the current Webjet share price, this implies potential upside of 15% for investors over the next 12 months.

What did the broker say?

Goldman notes that there has been yet another change in the outlook for the Australian travel industry, this time in a positive way.

It commented: "The outlook for travel in Australia has yet again changed significantly since the last update, this time in a positive direction with international reopening officially announced. Internationally, while the outbreak of the Delta variant slowed domestic recovery into September, frequent data updates indicate that recovery has since progressed positively, especially in terms of international travel recovery."

This has led to the broker maintaining its domestic travel recovery estimates but bringing forward its international travel recovery timeline.

Goldman said: "We maintain our expectations for broader domestic travel recovery in Australia to begin through December and return to pre-Delta wave levels by March 2022, but update our views on International travel recovery from Australia to begin by the end of this year. We now expect pre-COVID travel levels to be achieved in late FY23 rather than FY24 in terms of international travel from Australia in view of the quick rebound seen in other regions."

"We also bring forward our expectations of regaining pre-COVID international travel levels in Europe and the US to FY23, while we expect Asia to continue to lag," it added.

What does this mean for Webjet?

Goldman believes the sum of the above will be double digit earnings growth for Webjet between FY 2019 and FY 2024.

It explained: "Our revised earnings outlook implies a 5 year CAGR EBITDA growth of +11.6% over FY19-24e for Webjet, with Webbeds expected to grow at c. 16% CAGR over the same period driven by an improved focus in the Americas region and cost improvements at the other end of recovery."

Though, the good news for shareholders and the Webjet share price is that there could be upside to these forecasts. This is thanks to Webjet's strong balance sheet.

Goldman added: "We also believe that the recovery curve has now turned, implying a strengthening cash balance offering WEB the firepower to engage in strategic M&A opportunities where available."

"Overall, the stock currently trades at a 20.2x full dilution P/E at recovery (FY24), below the peer group multiple at 22.8x," it concluded.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Webjet Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

A smiling woman holds a Facebook like sign above her head.
Broker Notes

Why these ASX shares are rated as buys in April

Let's see what makes them bullish on these names right now.

Read more »

Australian dollar notes in the pocket of a man's jeans, symbolising dividends.
Broker Notes

Are CBA shares still a good buy for passive income?

A leading analyst delivers his verdict on CBA’s passive income appeal.

Read more »

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Broker Notes

Morgans names 2 ASX shares to buy and 1 to accumulate

What is the broker recommending investors do with these shares?

Read more »

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Broker Notes

2 ASX 200 shares to buy ahead of anticipated rally: expert

After a 9.1% drop between 27 February and 23 March, the ASX 200 reversed course last Tuesday.

Read more »

A group of people in a corporate setting do a collective high five.
Broker Notes

3 reasons to buy Ramsay Health Care shares today

A leading analyst expects Ramsay Health Care shares to keep outperforming in the months ahead.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Broker Notes

Bell Potter says this ASX 200 stock can rise 38% and pay a 6% dividend yield

Major upside and a generous dividend yield could be on offer with this name.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Is this ASX defence stock the next DroneShield?

Bell Potter thinks this stock could be the next to rocket. Let's find out why.

Read more »

Happy, tablet or doctor in a laboratory with research results or positive feedback after medical data analysis. Smile, vaccine or healthcare worker reading or working on futuristic science innovation.
Broker Notes

This ASX healthcare stock could almost double in value according to Bell Potter

The broker believes this stock is making major breakthroughs.

Read more »